The Next Wave

Tuesday, March 21, 2017

5:45am Arrivals and Breakfast
Provided by Forefront Collaborative

6:00am-7:15am Educational Activity

Haleakala Ballroom 4/5, Grand Wailea
Wailea, Hawaii

Activity Information
The target audience for this educational activity is dermatologists. Other healthcare professionals, including rheumatologists, physician assistants, and nurse practitioners who treat patients with psoriasis, may benefit from participation in this activity.


The workshop begins with a fast-paced and concise, TED-style talk on the latest developments in psoriasis treatment. Following the talk, learners will embark on an interactive educational journey exploring the evolution of the pathophysiologic understanding of psoriasis. Knowledge of the disease pathogenesis and mechanisms of action of new and emerging systemic agents is increasingly critical for dermatologists to optimally manage their patients’ psoriasis.

A roundtable discussion will wrap up the workshop, providing an o­­pportunity for participants to hear from, and interact with, expert faculty on the clinical application of the available data.


As a result of participation in this educational activity, participants should be able to:

  1. Describe recent advances in treatment of moderate to severe psoriasis.
  2. Explain how improved understanding of psoriasis pathogenesis informs the development of increasingly efficacious psoriasis treatments.
  3. Utilize rational strategies for switching, escalating, and adjusting treatments in patients with moderate to severe psoriasis who are not achieving treatment targets.

CME Info
Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the activity handout prior to the start of the activity
The content of this activity was independently peer reviewed. The reviewers of this activity have no relevant financial relationships to disclose.
Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Forefront Collaborative designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dr. Korman
Neil J. Korman, MD, PhD
Director, Clinical Trials Unit
Clinical Director, Murdough Family Center for Psoriasis
Professor, Dermatology
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio
Dr. Strober
Bruce E. Strober, MD, PhD
Professor and Chair,
Department of Dermatology
University of Connecticut Health Center
Farmington, Connecticut
Dr. Stein Gold
Linda Stein Gold, MD
Director of Dermatology Clinical Research,
Division Head, Dermatology
Henry Ford Health System
Detroit and West Bloomfield, Michigan
This live activity is provided by Forefront Collaborative and is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit
Forefront Collaborative
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative.
Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please contact Miranda Armie at 317.846.2761 prior to this activity